Draft Senate Drug Shortages Bill Sparks Stakeholder Debate over 340B Provisions

Stakeholders recently submitted feedback on a draft Senate Finance Committee drug shortages bill with 340B implications.
A draft Senate bill, which would offer bonus payments to hospitals that stockpile certain generic drugs and forgo other rebates [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law

Attorneys representing the drug industry, the state of Louisiana, and Louisiana health centers presented oral arguments before a federal district court.
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Michigan Lawmakers, Witnesses Spar Over 340B Contract Pharmacy Access Bill in Key Hearing

Ben Frederick, associate vice president of advocacy and government relations at Memorial Healthcare, testified in support of a 340B contract pharmacy access bill at a Michigan state house hearing.
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Today’s 340B Congressional Hearing Will Include Multiple 340B Critics, Leading Hospital and Health Center Advocates

Dr. Anthony DiGiorgio, a free-market physician at UCSF who suggested last year that Congress could consider ending the 340B program, is one of four witnesses who will testify at a June 4 Congressional hearing on 340B.
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live